Markets.com Logo

JAGX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.8492$
  • Previous Close
    1.8256$
  • 52 Week Change
    33.46$
  • Day Range
    0.02$
  • 52 Week High/Low
    1.79$ - 35.25$
  • Dividend Per Share
    --
  • Market cap
    4 067 K$
  • EPS
    -10.26
  • Beta
    0.443
  • Volume
    --

About

Jaguar Health, Inc. (JAGX.US) is a commercial-stage pharmaceutical company focused on developing and commercializing gastrointestinal products for both humans and animals. The company's human health product is Mytesi® (crofelemer), approved by the FDA for symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar Health is also working to develop crofelemer for other indications, including cancer therapy-related diarrhea. The animal health division, Napo Pharmaceuticals, focuses on developing and commercializing proprietary gastrointestinal pharmaceuticals for companion and production animals.

Market Resilience Amidst Geopolitical Tensions: HSBC's Optimistic Strategic Outlook

Sophia Claire|--
Apple stock analysis: Could Apple stock soar under its new CEO John Ternus?

Apple stock analysis: Could Apple stock soar under its new CEO John Ternus?

Ghko B|--
BTC/EUR Outlook April 2026: Will Bitcoin Ignite a Massive Bull Run for European Investors?

BTC/EUR Outlook April 2026: Will Bitcoin Ignite a Massive Bull Run for European Investors?

Ghko B|--

Kuwait Declares Force Majeure on Oil Shipments Amidst Strait of Hormuz Blockade: Impacts and Recovery Outlook

Emma Rose|--

Iran's Uranium Transfer: Navigating Complex Logistics and Diplomatic Hurdles

Emma Rose|--

Understanding Oil Price Dynamics: Beyond the Headline Number

Emma Rose|--

Bank of Japan Leans Towards Keeping Rates Unchanged Amid Middle East Conflict Uncertainty

Sophia Claire|--

Factors

Please do not add any introductory or concluding remarks. Clinical Trial Results: Positive or negative results from Jaguar Health's clinical trials for its drug products significantly impact investor confidence and stock price.

Regulatory Approvals: FDA approval of Jaguar Health's drugs like Mytesi for new indications can lead to increased revenue potential and a higher stock price.

Financial Performance: Jaguar Health's revenue, profitability, and cash flow influence investor sentiment; positive financial reports can boost stock value.

Market Conditions: Overall market trends, economic conditions, and investor risk appetite impact stock valuations; a bullish market often lifts even struggling stocks.

Competition: The presence of competing drugs or therapies in the market can affect Jaguar Health's market share and pricing power, influencing its stock price.

Partnerships/Collaborations: Strategic partnerships with other pharmaceutical companies or research institutions can enhance Jaguar Health's credibility and prospects, driving up its stock price.

Dilution: Issuing new shares (dilution) can decrease the value of existing shares, putting downward pressure on the stock price.

News & Events: Company-specific news, industry events, and media coverage can create volatility in the stock price as investors react to new information.

Analyst Ratings: Analyst upgrades or downgrades can influence investor perception and trading activity, impacting the stock price.

Investor Sentiment: Overall investor mood toward Jaguar Health and the biotech sector can significantly affect trading volume and stock price movements.

People Also Watch

Latest news

Hormuz Strait: The Flashpoint in US-Iran Talks and Persian Gulf Concerns

Ava Grace|--

Fed Nominee Kevin Warsh Emphasizes Central Bank's Role and Independence at Crucial Economic Juncture

Sophia Claire|--

Geopolitical Tweets Reshape Oil Markets: Citadel's Insights on Navigating Trump-Era Volatility

Liam James|--

Latest Education Articles

S&P 500 vs Nasdaq, Which Is Better?

S&P 500 vs Nasdaq, Which Is Better?

Julian Parker|--
How Oil Prices Move Crypto Markets: From Crude Shocks to Bitcoin Volatility

How Oil Prices Move Crypto Markets: From Crude Shocks to Bitcoin Volatility

Julian Parker|--
Best High Leverage Forex and CFD Brokers in 2026: Markets.com, Plus500, eToro, FxPro

Best High Leverage Forex and CFD Brokers in 2026: Markets.com, Plus500, eToro, FxPro

Julian Parker|--
Recommended Topics